# A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental Pain

> **NCT02837952** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 123 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** FDC IBU/APAP 250 mg/500 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02837952
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-31
- **Primary completion:** 2017-02-01
- **Final completion:** 2017-02-01
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2018-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02837952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02837952, "A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02837952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*